Pharmacological validation of a novel exopolysaccharide from <i>Streptomyces</i> sp. 139 to effectively inhibit cytokine storms.

It was significantly reduced after Ebosin or positive control treatment, and all of them had significant difference ( p < 0.05), the Ebosin-L, Ebosin-M and positive control groups also had highly significant differences compared with the LPS group ( p < 0.01). 3.5.

also in 132,142 other papers

After treatment with Ebosin, a decreasing trend was detected for 14 cytokines in the serum, and a decrease in the expression of 7 factors in the lung tissue.

also in 47,180 other papers